Neuromedin-K receptor — Drug Target

All drugs that target Neuromedin-K receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Neurokinin 3 Receptor Antagonist [EPC]

Marketed (1)

• Veozah · Astellas Pharma · Neurokinin 3 Receptor Antagonist [EPC] · Neuroscience
  Veozah works by binding to the Neuromedin-K receptor, which helps to alleviate vasomotor symptoms.

Phase 2 pipeline (1)

• Eledone Peptide · Neuroscience
  Eledoisin works by binding to the Neuromedin-K receptor, which is involved in various physiological processes.